FR2547730B1 - Medicament hypolipidemiant contenant comme ingredient actif la d-3-acetoxy-cis-2,3-dihydro-5-(2-(dimethylamino)ethyl)-2-(p-methoxyphenyl)-1,5-benzothiazepine-4(5h)-one ou un de ses sels d'addition d'acides acceptables en pharmacie - Google Patents

Medicament hypolipidemiant contenant comme ingredient actif la d-3-acetoxy-cis-2,3-dihydro-5-(2-(dimethylamino)ethyl)-2-(p-methoxyphenyl)-1,5-benzothiazepine-4(5h)-one ou un de ses sels d'addition d'acides acceptables en pharmacie

Info

Publication number
FR2547730B1
FR2547730B1 FR8409077A FR8409077A FR2547730B1 FR 2547730 B1 FR2547730 B1 FR 2547730B1 FR 8409077 A FR8409077 A FR 8409077A FR 8409077 A FR8409077 A FR 8409077A FR 2547730 B1 FR2547730 B1 FR 2547730B1
Authority
FR
France
Prior art keywords
benzothiazepine
acetoxy
pharmacy
methoxyphenyl
dihydro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8409077A
Other languages
English (en)
Other versions
FR2547730A1 (fr
Inventor
Kohki Takashima
Shuji Nitta
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tanabe Seiyaku Co Ltd
Original Assignee
Tanabe Seiyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co Ltd filed Critical Tanabe Seiyaku Co Ltd
Publication of FR2547730A1 publication Critical patent/FR2547730A1/fr
Application granted granted Critical
Publication of FR2547730B1 publication Critical patent/FR2547730B1/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
FR8409077A 1983-06-10 1984-06-08 Medicament hypolipidemiant contenant comme ingredient actif la d-3-acetoxy-cis-2,3-dihydro-5-(2-(dimethylamino)ethyl)-2-(p-methoxyphenyl)-1,5-benzothiazepine-4(5h)-one ou un de ses sels d'addition d'acides acceptables en pharmacie Expired FR2547730B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58104691A JPS59231018A (ja) 1983-06-10 1983-06-10 抗脂血剤

Publications (2)

Publication Number Publication Date
FR2547730A1 FR2547730A1 (fr) 1984-12-28
FR2547730B1 true FR2547730B1 (fr) 1987-11-13

Family

ID=14387491

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8409077A Expired FR2547730B1 (fr) 1983-06-10 1984-06-08 Medicament hypolipidemiant contenant comme ingredient actif la d-3-acetoxy-cis-2,3-dihydro-5-(2-(dimethylamino)ethyl)-2-(p-methoxyphenyl)-1,5-benzothiazepine-4(5h)-one ou un de ses sels d'addition d'acides acceptables en pharmacie

Country Status (12)

Country Link
JP (1) JPS59231018A (fr)
BE (1) BE899867A (fr)
CH (1) CH661867A5 (fr)
DE (1) DE3419425A1 (fr)
DK (1) DK164021C (fr)
FR (1) FR2547730B1 (fr)
GB (1) GB2141027B (fr)
HK (1) HK45489A (fr)
IT (1) IT1196710B (fr)
NL (1) NL8401793A (fr)
SE (1) SE465352B (fr)
SG (1) SG21089G (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4778791A (en) * 1986-05-16 1988-10-18 Tanabe Seiyaku Co., Ltd. Pharmaceutical composition for improving constitution of lipids in blood
JPS63107925A (ja) * 1986-05-23 1988-05-12 Tanabe Seiyaku Co Ltd 動脈硬化症予防・治療剤
AT389446B (de) * 1987-10-08 1989-12-11 Tanabe Seiyaku Co Verwendung eines 8-chlorobenzothiazepins zur herstellung eines arzneimittels
DE3737741A1 (de) * 1987-11-06 1989-05-18 Goedecke Ag Oral anzuwendende arzneiform zur einmal taeglichen behandlung der hypertonie mit diltiazemhydrochlorid
GB9423172D0 (en) * 1994-11-17 1995-01-04 Wellcom Foundation The Limited Hypolipidemic benzothiazepines

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3562257A (en) * 1967-10-28 1971-02-09 Tanabe Seiyaku Co Benzothiazepine derivatives
JPS58208222A (ja) * 1982-05-28 1983-12-03 Japan Found Cancer 抗腫瘍剤効果増強剤
JPS5970611A (ja) * 1982-10-15 1984-04-21 Tanabe Seiyaku Co Ltd 医薬組成物

Also Published As

Publication number Publication date
DK164021C (da) 1992-09-28
DE3419425A1 (de) 1984-12-13
JPS59231018A (ja) 1984-12-25
SG21089G (en) 1990-01-26
HK45489A (en) 1989-06-16
GB2141027A (en) 1984-12-12
JPS6317810B2 (fr) 1988-04-15
GB8414498D0 (en) 1984-07-11
BE899867A (fr) 1984-10-01
CH661867A5 (de) 1987-08-31
IT8467596A0 (it) 1984-06-08
DK164021B (da) 1992-05-04
DK284084A (da) 1984-12-11
DK284084D0 (da) 1984-06-08
SE8403042L (sv) 1984-12-11
NL8401793A (nl) 1985-01-02
FR2547730A1 (fr) 1984-12-28
IT8467596A1 (it) 1985-12-08
SE8403042D0 (sv) 1984-06-06
SE465352B (sv) 1991-09-02
GB2141027B (en) 1986-10-22
DE3419425C2 (fr) 1989-06-08
IT1196710B (it) 1988-11-25

Similar Documents

Publication Publication Date Title
LU90956I2 (fr) Metvix principe actif méthylaminolevulinique sous forme d'un selde préférence l'hyhrochlorure méthylaminolevulinique
TNSN95076A1 (fr) Forme de dosage ii d'unite multiple en comprime
IT8647603A0 (it) Procedimento di trattamento per forme farmaceutiche di dosaggio rivestite per ridurne la collosita'
EA200000468A1 (ru) Терапевтическая композиция для введения толтеродина с контролируемым высвобождением
TW376319B (en) Pharmaceutical composition containing risperidone pamoate and having a long acting activity for treating psychoses induced by the release of dopamine
UA40589C2 (uk) Спосіб лікування людини, що страждає від вірусної інфекції, фармацевтична композиція, комбінація речовин для отримання ліків та фармацевтична комбінація
IL80149A (en) Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases
ITMI922953A1 (it) Inibitori a doppia attivita' biologica di no sintasi e cicloossigenasi procedimento per la loro preparazione e composizioni terapeutiche che li contengono.
DK0503440T3 (da) Sumatriptanholdige lægemidler
RU94027563A (ru) Соединения-ингибиторы вич протеазы, их использование для лечения спида, форикомпозиция
UA41446C2 (uk) Застосування фумагілолу та його похідних для одержання ліків, призначених для боротьби з кишковими інфекціями, та фармацевтична композиція на їх основі
FR2698788B1 (fr) Composition pharmaceutique effervescente contenant de l'ibuprofène et son procédé de préparation.
RU93032613A (ru) Фармацевтический препарат для лечения пациентов с пролонгированным временем коагуляции, способ лечения пациентов, применение epi ингибитора для получения фармацевтического препарата
PL340631A1 (en) Azelaic acid containing composition
HUT38097A (en) Process for preparing substituted benzopyrans and pharmaceutical compositions containing them as active substances
TNSN90021A1 (fr) Procede de preparation de tetrahydroimidazo (1,4) benzodiazepin -2- thiones antivirales
FR2547730B1 (fr) Medicament hypolipidemiant contenant comme ingredient actif la d-3-acetoxy-cis-2,3-dihydro-5-(2-(dimethylamino)ethyl)-2-(p-methoxyphenyl)-1,5-benzothiazepine-4(5h)-one ou un de ses sels d'addition d'acides acceptables en pharmacie
RU2000106042A (ru) Способ повышения биологической доступности фексофенадина и его производных
ATE110723T1 (de) Verbindungen mit magensäureinhibitorwirkung und verfahren zur herstellung.
GB9108629D0 (en) Heterocyclic pharmaceutical compounds,preparation and use
ATE81007T1 (de) Wirkstoff mit die nierenfunktion verbesserndem und diuretischem effekt und verwendung eines darin enthaltenen benzothiazepin-derivates.
RU98101105A (ru) Новое применение в медицинских целях
WO2001007029A3 (fr) Guanidines substitutees et utilisation correspondante
ATE80036T1 (de) Pharmazeutische zusammensetzung, die eine 8-chlor-benzothiazepin-verbindung enthaelt und ihre verwendung.
FR2604707B1 (fr) Procede de preparation d'un compose therapeutique actif

Legal Events

Date Code Title Description
CA Change of address
ST Notification of lapse